NCT03659253

Brief Summary

This study will be one of the first to systematically evaluate strategies to improve the implementation of a T\&T strategy in a concentrated epidemic in Asia. HATI Project is an implementation research designed, of which consisted of phase I as observation of available standard practice and data collection and phase II implementation of intervention of intervention designed based on the results of phase I. The first year observation study showed that there are poor cascade of HIV care. The first is the low coverage of HIV test uptake. Along the HIV test and treatment cascade there are substantial reductions. Furthermore, In the qualitative analysis we found several reasons for the study population for not coming to the ARV sites after being diagnosed with HIV, e.g. social and administrative reasons such as not possessing ID card and unsuited hospital opening hours, etc. Another important finding was the requested laboratory testing by the physicians prior to ART initiation, such as Levels of Haemoglobin, serum transaminases, creatinine, and chest X-ray (manuscript in preparation). The aims of the proposed interventions are:

  1. 1.Increase uptake of HIV testing
  2. 2.Increase uptake of HIV treatment initiation
  3. 3.Reduce time from testing to treatment initiation
  4. 4.Increase percentage of treatment adherence
  5. 5.Reducing loss to follow-up on ART
  6. 6.Improve treatment outcomes (virological suppression)
  7. 7.Oral fluid-based testing (self-testing) as a strategy to overcome barriers of testing
  8. 8.Simplification of ART initiation
  9. 9.CBOs and Brothel-based ART service
  10. 10.SMS reminders to increase treatment adherence
  11. 11.Motivational Interviewing Approach to increase treatment uptake \& adherence

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
827

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2017

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 22, 2017

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

September 3, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 6, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

February 5, 2020

Status Verified

February 1, 2020

Enrollment Period

2.1 years

First QC Date

September 3, 2018

Last Update Submit

February 4, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of virologically suppressed

    Proportion of people from each key population who are virologically suppressed 12 months after HIV diagnosis. Analyses will be conducted separately for each key affected population

    12 months

Secondary Outcomes (4)

  • Quantify and comparing other components of the HIV treatment cascade/continuum of care

    12 months

  • Assess the safety and acceptability of early ART Initiation

    12 months

  • Assess behavioural aspects of Test and Treat Strategy

    12 months

  • Number of participants that virologically suppressed

    12 months

Study Arms (6)

Oral Fluid Based Self Testing

EXPERIMENTAL

All study participants that received intervention and meet inclusion criteria intervention that will be offered OFT

Diagnostic Test: Oral Fluid Based Self TestingProcedure: Simplified ART InitiationBehavioral: SMS REMINDER

Control Group

NO INTERVENTION

All HIV Patients in the clinic that not received any intervention

Simplified ART Initiation

EXPERIMENTAL

All study participants that received intervention and meet inclusion criteria intervention that will be offered SAI

Procedure: Simplified ART Initiation

CBO AND BROTHEL-BASED ART SERVICE

EXPERIMENTAL

All patients coming to brothel or Community Based Organization services will be offered to get tested and received ART

Procedure: Simplified ART InitiationProcedure: CBO AND BROTHEL-BASED ART SERVICEBehavioral: SMS REMINDER

SMS Reminder

EXPERIMENTAL

All patients that recently found HIV Positive "HIV Naive" offered to get SMS Reminder

Procedure: Simplified ART InitiationBehavioral: SMS REMINDERProcedure: MOTIVATIONAL INTERVIEWING

Motivational Interviewing

EXPERIMENTAL

PWID in Jakarta and Bandung that recently found HIV Positive or lost to follow up ARV offered MI intervention

Procedure: MOTIVATIONAL INTERVIEWING

Interventions

The intervention will introduce provider supervised and unsupervised self-testing as an option for early HIV diagnosis among MSM community in Denpasar Bali Indonesia.

Also known as: OFT
Oral Fluid Based Self Testing

In this intervention, there will be a change in the clinical practice of ART initiation. In the current practice, clients are asked to perform full pre-ART laboratory examination (complete blood count, liver and renal function tests) before decision of ART initiation. In this intervention, the study participants who are already confirmed as HIV positive and meet specific clinical criteria (see below) will initiate ART (antiretroviral therapy) immediately (after clients' approval) without having to perform full pre-ART laboratory examination. Here, laboratory criteria for initiating ART will be simplified and specific laboratory examination, I.e. creatinine test will be delayed in two weeks after ART initiation.

Also known as: SAI
CBO AND BROTHEL-BASED ART SERVICEOral Fluid Based Self TestingSMS ReminderSimplified ART Initiation

The CBOs involved in this intervention are Kebaya and Vesta. Kebaya is an CBO working for Transgender (TG) community. It serves as community gathering place for TG and others, as HIV testing site on regular bases, and also as shelter for homeless HIV patients. The proposed intervention Is that HATI Project will provide HIV testing and treatment in the community, CBO and brothel in collaboration with nearby Puskesmas.

Also known as: CBO ART SERVICE
CBO AND BROTHEL-BASED ART SERVICE
SMS REMINDERBEHAVIORAL

HATI SMS reminder: short message services as reminders to inform ART patients when to take medication, visit the clinics (1 week before the next visit) and remind if they miss clinic appointment.

CBO AND BROTHEL-BASED ART SERVICEOral Fluid Based Self TestingSMS Reminder

The approach used in this intervention is an individual counselling with a MI approach, as it is considered a brief form of therapy have been known to be effective in improving HIV treatment adherence. The sessions will be held from 3 to up to 10 MI counselling over 6-month period of intervention. The goal of this intervention is to help PWID gain an understanding of their medication-taking behaviors and the actions necessary to successfully maintain a high level of adherence

Also known as: MI
Motivational InterviewingSMS Reminder

Eligibility Criteria

Age16 Years - 50 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsFemale Male Transgender
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • OFT :
  • Refused HTC testing at clinic or outreach setting?
  • Aged 18 years and over;
  • Not known to be HIV-infected;
  • Self-reported anal sex with a man in the last 12 months;
  • SAI \& CBO
  • WHO clinical stage 1 and 2
  • Age \< 50 years old
  • Free of Tuberculosis suspicion (based on TB screening form)
  • Not suffering from uncontrolled hypertension (blood pressure more than 140 mmHg) and or diabetes (clinical history based on patients interview)
  • BMI above 18.5 kg/m2
  • ARV naïve
  • Well informed and agree to receive ARV
  • SMS Reminder :
  • Age: ≥ 16 years old
  • +8 more criteria

You may not qualify if:

  • Known HIV Positive
  • Refuse to be included in the intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Yayasan Kerti Praja

Denpasar, Bali, 80223, Indonesia

Location

Dr. Sardjito Hospital, Yogyakarta Indonesia

Yogyakarta, DI Yogyakarta, 55281, Indonesia

Location

Atma Jaya HIV-AIDS Research Centre

Jakarta, DKI Jakarta, 12930, Indonesia

Location

Hasan Sadikin Hospital, Bandung, Indonesia

Bandung, West Java, 40161, Indonesia

Location

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Interventions

Motivational Interviewing

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

Directive CounselingCounselingMental Health ServicesBehavioral Disciplines and ActivitiesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Yanri W Subronto, PhD

    Gadjah Mada University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD,PhD,Sp.PD-KPTI,FINASIM

Study Record Dates

First Submitted

September 3, 2018

First Posted

September 6, 2018

Study Start

November 22, 2017

Primary Completion

December 31, 2019

Study Completion

December 31, 2019

Last Updated

February 5, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations